Erlanger announced Tuesday a strategic partnership with Qventus, a provider of AI-based care operations automation software, to drive strategic surgical growth and increase patient access to the most advanced, minimally invasive da Vinci procedures. This investment in Qventus’ Surgical Growth Solution is part of Erlanger’s commitment to leveraging the latest AI technology and best-in-class tools to serve more patients, streamline operations, and better support dedicated staff, said officials.
Health systems across the U.S.
face operational inefficiencies that shrink already thin margins which are required to deliver exceptional care to patients. Surgery is a key revenue driver where every percentage of growth can represent millions of dollars of impact, yet 30 percent of OR time goes unused. Erlanger selected Qventus’ Surgical Growth Solution to drive strategic growth, turning Erlanger’s goals into action by filling ORs with high-value cases, maximizing robotics investments, and strengthening referral patterns with one-of-a-kind market insights, said officials.
“At Erlanger, we are always seeking ways to do more for our community and our staff,” said Misti Mattox, vice president of Surgical Services at Erlanger. “Qventus’ AI technology goes beyond a simple scheduling tool—it’s a complete solution that fills every white space with the best-fit surgeon and case. This means our clinicians can focus more on patient care and less on administrative tasks, while our community gains access to the very best in healthcare.”
Qventus’ suite of AI teammates works 24/7 to deliver a seamless, white-glove experience to surgeons and clinic schedulers. Machine learning algorithms are personalized to surgeon preferences and behavior patterns, intelligently matching open OR slots with the right surgeons, eliminating first-come, first-served inefficiencies and prioritizing high-value cases.
“Forward-thinking organizations like Erlanger have all of the specialists, staff, OR space, and robotic assets to deliver exceptional care but it’s nearly impossible to maximize all of those resources with the outdated technology that most health systems in the U.S. rely on,” said Mudit Garg, CEO, Qventus. “Our Surgical Growth Solution was developed in close partnership with hospital leaders and providers who grapple with these challenges daily. With Erlanger as a new strategic partner, we can continue to evolve and refine our suite of AI teammates to best serve their specific patient needs.”
Qventus’ Surgical Growth Solution delivers an average 11X ROI for its health system partners. Ardent Health achieved 41 percent growth in robotics volume and West Tennessee Healthcare added a record 61 cases to its schedule in the first 100 days of Qventus thanks to streamlined booking for independent surgeons and clinic schedulers. Allina Health, one of the nation’s largest nonprofit health systems, added over 50 robotic cases in the last quarter of 2024, resulting in a $5.8 million Qventus-affected contribution margin.